Unlearn AI

Unlearn AI is a biotechnology company focused on leveraging artificial intelligence and patient digital twins to optimize clinical trials. Its core product, the TrialPioneer platform, builds high-precision predictive models to help research teams accelerate trial design, reduce sample size requirements, and improve decision quality, addressing the industry pain points of high trial costs and long timelines.

Rating:

Visit Website

clinical trials AIpatient digital twinsTwinRCTssynthetic control armsAI-driven clinical trial designTrialPioneer platformreduce clinical trial costsrare disease clinical trial solutions

Features of Unlearn AI

An integrated AI platform called TrialPioneer that supports end-to-end, design-to-analysis workflows.

Leverage generative AI to build patient digital twins and predict each patient's natural disease progression in the control arm.

The platform includes intelligent search capabilities that automatically consolidate literature and regulatory precedents, speeding up information alignment.

Supports validation of clinical and statistical hypotheses using historical data to assess trial design feasibility.

Scenario modeling to build interpretable trial design scenarios and simulate how different parameters affect outcomes.

Create synthetic control arms via digital twins to reduce the number of control patients required in traditional trials.

The platform blends disease modeling, Bayesian prognostic covariate adjustment, survival analysis, and other statistical methods.

Provides flexible deployment options—cloud or on-premises—empowering sponsors to build custom models using their own data.

Use Cases of Unlearn AI

In rare disease drug development, when randomized controlled trials are not feasible, to construct reliable synthetic control arms for efficacy comparisons.

When designing new clinical trial protocols, to simulate how different endpoints, sample sizes, and eligibility criteria affect results.

Sponsors can reassess historical trial data in retrospective analyses using regulatory-compliant methods to unlock new value.

During interim analyses, the platform provides data-driven support for decisions to continue or terminate a trial.

Biostatisticians validating clinical hypotheses can leverage the platform's integrated historical data to assess statistical power.

When drug development teams need to speed up enrollment and shorten overall trial timelines, use digital twin technology to optimize trial design.

When cost reduction is a priority, explore reducing the number of control-arm patients to optimize resource allocation.

Designing and optimizing Phase II or III trials in neuroscience, immunology, metabolic diseases, and other therapeutic areas.

FAQ about Unlearn AI

QWhat is Unlearn AI?

Unlearn AI is a biotechnology company that leverages artificial intelligence and patient digital twin technology to optimize clinical trial design and efficiency.

QWhat is the core technology of Unlearn AI?

Its core technology is building patient digital twins—a high-precision AI predictive model trained on historical data that simulates the natural progression of a patient's disease without intervention.

QWhat are the main features of the TrialPioneer platform?

The TrialPioneer platform primarily integrates intelligent search, historical data validation, and trial scenario simulation, supporting an end-to-end design-to-analysis workflow.

QWhat potential benefits does Unlearn AI's digital twin technology offer for clinical trials?

Benefits include reducing the number of control-arm patients recruited, shortening trial timelines, lowering costs, and enabling more data-driven trial design and decision-making.

QWhat disease areas is Unlearn AI's technology currently applied to?

According to public information, its technology has been applied across neuroscience (e.g., Alzheimer's disease, amyotrophic lateral sclerosis), immunology, metabolic diseases, cardiovascular, and other areas.

QHow is Unlearn AI's solution deployed?

The solution offers flexible deployment options, allowing sponsors to build customized AI models in cloud or on-premises environments using their own data.

QHas Unlearn AI's digital twin approach been regulatory approved?

According to the company, its TwinRCTs™ methodology has received a favorable qualification opinion from the European Medicines Agency (EMA) and is recognized by the U.S. FDA.

QWho are the potential users or institutions for Unlearn AI's platform?

Primarily aimed at pharmaceutical and biotech R&D and clinical teams, academic research institutions, and contract research organizations (CROs) responsible for clinical trial design and optimization.

Similar Tools

Thinking Machines AI

Thinking Machines AI is a company focused on AI research and product development, offering the Tinker model fine-tuning API platform. The platform gives researchers and developers deep control over model training while managing the underlying infrastructure, lowering the barrier to customizing large language models and promoting more democratic, collaborative AI development.

Tempus AI

Tempus AI is a precision medicine company that uses artificial intelligence and data platforms to integrate multimodal medical data, delivering data-driven solutions for clinical decision support, medical research and drug development.

Fiddler AI

Fiddler AI is an enterprise control plane for AI agents and predictive applications, delivering unified observability, security and governance. It enables engineering, risk and compliance teams to monitor, understand and control AI behavior—improving transparency, reliability and accountability across the full development-to-production lifecycle.

Personal AI

Personal AI is an enterprise-grade distributed edge AI platform focused on building and deploying small language models (SLMs) trained on users' proprietary data to create personalized digital twins or brand representatives. The platform enables deep customization of AI personas, secure deployment, and seamless business integration, boosting efficiency in knowledge management, customer interactions, and workplace collaboration.

Cradle AI

Cradle AI is a scientific platform that applies generative artificial intelligence to protein engineering and drug discovery, letting biologists design and optimize antibodies, enzymes and other biologics while cutting experimental cycles and boosting success rates.

Tamarind Bio AI

Tamarind Bio AI is a computational biology SaaS cloud platform that integrates AI with physical computing methods to help scientists efficiently tackle complex research tasks such as protein design, antibody engineering, and drug discovery.

SmartSpeed AI

SmartSpeed AI is an AI-powered clinical decision support platform that focuses on using medical imaging analysis to aid in diagnosing and optimizing treatment workflows for neurovascular and cardiovascular diseases.

Clearstep AI

Clearstep AI is a clinically advanced AI-powered platform for healthcare systems that optimizes patient care management workflows using artificial intelligence. Its core capabilities include intelligent triage and routing, automated appointment scheduling, and patient guidance, designed to help healthcare organizations improve operational efficiency and enhance the patient care journey.

HEALWELL AI

HEALWELL AI is a provider of AI-driven clinical decision support systems focused on preventive care. By leveraging early disease detection technology, it helps doctors improve diagnostic accuracy and efficiency, ultimately improving patient health outcomes.

Openlayer AI

Openlayer AI is a unified AI governance and observability platform designed to help enterprises securely and compliantly build, test, deploy, and monitor machine learning and large language model systems, boosting deployment confidence and operational efficiency.